Genetic Therapy Shows Promise in Halting ALS
The CTx1000, a single-dose genetic medication, targets pathological accumulations of the TDP-43 protein, offering hope for treating various forms of dementia.
Source: medindia.net
Professor Ittner News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Professor Ittner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Professor Ittner Today - Breaking & Trending Today
Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice
Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.
Source: news-medical.net
New genetic therapy holds promise for ALS and frontotemporal dementia
Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and
Source: newswise.com